Name: Global Diabetes Devices and Drugs Market Insights, Forecast to 2035
Brand: Extent Research
Price: 3500 USD
Availability: InStock
Rating: 4.6 (163 reviews)

Global Diabetes Devices and Drugs Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

The global Diabetes Devices and Drugs Market study published by Extent Research offers in-depth growth trajectory of the global Diabetes Devices and Drugs market. The compilation of historical and future data of the market helps paint a transparent picture of the of the market expansion in terms of valuation and consumer preference. The market research report encompasses all the important macroscopic and microscopic factors including consumer preference, government policies, business strategies, growth stimulators, and foreseeable market trends. The research report basically covers the postulates that have a significant influence on the global Diabetes Devices and Drugs market growth during the forecast growth. All the future changes and the modernization taking place in the Diabetes Devices and Drugs landscape is also provided for mapping the market status.

Data provided by Extent Research. Source: https://www.extentresearch.com/diabetes-devices-and-drugs-market

The geographical distribution of the market includes regions such as North America, Europe, Asia Pacific, Latin America, Middle East & Africa which are an attractive hub for the market. All these regions help gain more knowledge about the market volume, size, and forecasts at the global level. Also, it offers evaluated data and the global market size of the key market players in each region. Some of the leading players in the global Diabetes Devices and Drugs market include Medtronic, BD, Johnson & Johnson, Abbott Laboratories, Novo Nordisk, Bristol-Myers Squibb, DexCom, Companion Medical, GlaxoSmithKline, Glenmark Pharmaceuticals, Novartis, Roche, Sanofi, MSD, Astrazeneca, Takeda, North China Pharmaceutical Group Corporation, Huadong Medicine, Dongbao Pharmaceutical, Hisun Pharmacy, KELUN, Ginwa, Tianan Pharmaceutical, . Even the industry-changing and sculpting factors are also covered in this market research report.

The report also dispenses a wide array of factors that influence the market performance, market strength & weaknesses, market status, and developmental strategies of the global Diabetes Devices and Drugs market. Other aspects such as costing analysis, supply & demand chain, production processes, and customer base are also analyzed to confer precise competitiveness in the market.

In conclusion, the global Diabetes Devices and Drugs market report bestows the competitive analysis, business strategies, and value chain analysis for aiding the market players, especially new entrants, in setting their priorities accordingly. The insightful market analysis possesses holistic knowledge of the global Diabetes Devices and Drugs market.

Segmentation of the Global Diabetes Devices and Drugs Market:

By Product type

Diabetes Devices, Diabetes Drugs,

by Application

Diagnostic/Clinics, ICUs, Home Healthcare,

Report Scope and Market Segmentation

ATTRIBUTES	Global Diabetes Devices and Drugs Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global Diabetes Devices and Drugs Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Diabetes Devices and Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2035
        1.2.2 Diabetes Devices
        1.2.3 Diabetes Drugs
    1.3 Market by Application
        1.3.1 Global Diabetes Devices and Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2035
        1.3.2 Diagnostic/Clinics
        1.3.3 ICUs
        1.3.4 Home Healthcare
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Diabetes Devices and Drugs Market Perspective (2017-2035)
    2.2 Diabetes Devices and Drugs Growth Trends by Region
        2.2.1 Diabetes Devices and Drugs Market Size by Region: 2017 VS 2021 VS 2035
        2.2.2 Diabetes Devices and Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Diabetes Devices and Drugs Forecasted Market Size by Region (2023-2035)
    2.3 Diabetes Devices and Drugs Market Dynamics
        2.3.1 Diabetes Devices and Drugs Industry Trends
        2.3.2 Diabetes Devices and Drugs Market Drivers
        2.3.3 Diabetes Devices and Drugs Market Challenges
        2.3.4 Diabetes Devices and Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Diabetes Devices and Drugs Players by Revenue
        3.1.1 Global Top Diabetes Devices and Drugs Players by Revenue (2017-2022)
        3.1.2 Global Diabetes Devices and Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Diabetes Devices and Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Diabetes Devices and Drugs Revenue
    3.4 Global Diabetes Devices and Drugs Market Concentration Ratio
        3.4.1 Global Diabetes Devices and Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Diabetes Devices and Drugs Revenue in 2021
    3.5 Diabetes Devices and Drugs Key Players Head office and Area Served
    3.6 Key Players Diabetes Devices and Drugs Product Solution and Service
    3.7 Date of Enter into Diabetes Devices and Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetes Devices and Drugs Breakdown Data by Type
    4.1 Global Diabetes Devices and Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Diabetes Devices and Drugs Forecasted Market Size by Type (2023-2035)
5 Diabetes Devices and Drugs Breakdown Data by Application
    5.1 Global Diabetes Devices and Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Diabetes Devices and Drugs Forecasted Market Size by Application (2023-2035)
6 North America
    6.1 North America Diabetes Devices and Drugs Market Size (2017-2035)
    6.2 North America Diabetes Devices and Drugs Market Size by Type
        6.2.1 North America Diabetes Devices and Drugs Market Size by Type (2017-2022)
        6.2.2 North America Diabetes Devices and Drugs Market Size by Type (2023-2035)
        6.2.3 North America Diabetes Devices and Drugs Market Share by Type (2017-2035)
    6.3 North America Diabetes Devices and Drugs Market Size by Application
        6.3.1 North America Diabetes Devices and Drugs Market Size by Application (2017-2022)
        6.3.2 North America Diabetes Devices and Drugs Market Size by Application (2023-2035)
        6.3.3 North America Diabetes Devices and Drugs Market Share by Application (2017-2035)
    6.4 North America Diabetes Devices and Drugs Market Size by Country
        6.4.1 North America Diabetes Devices and Drugs Market Size by Country (2017-2022)
        6.4.2 North America Diabetes Devices and Drugs Market Size by Country (2023-2035)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Diabetes Devices and Drugs Market Size (2017-2035)
    7.2 Europe Diabetes Devices and Drugs Market Size by Type
        7.2.1 Europe Diabetes Devices and Drugs Market Size by Type (2017-2022)
        7.2.2 Europe Diabetes Devices and Drugs Market Size by Type (2023-2035)
        7.2.3 Europe Diabetes Devices and Drugs Market Share by Type (2017-2035)
    7.3 Europe Diabetes Devices and Drugs Market Size by Application
        7.3.1 Europe Diabetes Devices and Drugs Market Size by Application (2017-2022)
        7.3.2 Europe Diabetes Devices and Drugs Market Size by Application (2023-2035)
        7.3.3 Europe Diabetes Devices and Drugs Market Share by Application (2017-2035)
    7.4 Europe Diabetes Devices and Drugs Market Size by Country
        7.4.1 Europe Diabetes Devices and Drugs Market Size by Country (2017-2022)
        7.4.2 Europe Diabetes Devices and Drugs Market Size by Country (2023-2035)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Diabetes Devices and Drugs Market Size (2017-2035)
    8.2 Asia-Pacific Diabetes Devices and Drugs Market Size by Type
        8.2.1 Asia-Pacific Diabetes Devices and Drugs Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Diabetes Devices and Drugs Market Size by Type (2023-2035)
        8.2.3 Asia-Pacific Diabetes Devices and Drugs Market Share by Type (2017-2035)
    8.3 Asia-Pacific Diabetes Devices and Drugs Market Size by Application
        8.3.1 Asia-Pacific Diabetes Devices and Drugs Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Diabetes Devices and Drugs Market Size by Application (2023-2035)
        8.3.3 Asia-Pacific Diabetes Devices and Drugs Market Share by Application (2017-2035)
    8.4 Asia-Pacific Diabetes Devices and Drugs Market Size by Region
        8.4.1 Asia-Pacific Diabetes Devices and Drugs Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Diabetes Devices and Drugs Market Size by Region (2023-2035)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Diabetes Devices and Drugs Market Size (2017-2035)
    9.2 Latin America Diabetes Devices and Drugs Market Size by Type
        9.2.1 Latin America Diabetes Devices and Drugs Market Size by Type (2017-2022)
        9.2.2 Latin America Diabetes Devices and Drugs Market Size by Type (2023-2035)
        9.2.3 Latin America Diabetes Devices and Drugs Market Share by Type (2017-2035)
    9.3 Latin America Diabetes Devices and Drugs Market Size by Application
        9.3.1 Latin America Diabetes Devices and Drugs Market Size by Application (2017-2022)
        9.3.2 Latin America Diabetes Devices and Drugs Market Size by Application (2023-2035)
        9.3.3 Latin America Diabetes Devices and Drugs Market Share by Application (2017-2035)
    9.4 Latin America Diabetes Devices and Drugs Market Size by Country
        9.4.1 Latin America Diabetes Devices and Drugs Market Size by Country (2017-2022)
        9.4.2 Latin America Diabetes Devices and Drugs Market Size by Country (2023-2035)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Diabetes Devices and Drugs Market Size (2017-2035)
    10.2 Middle East & Africa Diabetes Devices and Drugs Market Size by Type
        10.2.1 Middle East & Africa Diabetes Devices and Drugs Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Diabetes Devices and Drugs Market Size by Type (2023-2035)
        10.2.3 Middle East & Africa Diabetes Devices and Drugs Market Share by Type (2017-2035)
    10.3 Middle East & Africa Diabetes Devices and Drugs Market Size by Application
        10.3.1 Middle East & Africa Diabetes Devices and Drugs Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Diabetes Devices and Drugs Market Size by Application (2023-2035)
        10.3.3 Middle East & Africa Diabetes Devices and Drugs Market Share by Application (2017-2035)
    10.4 Middle East & Africa Diabetes Devices and Drugs Market Size by Country
        10.4.1 Middle East & Africa Diabetes Devices and Drugs Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Diabetes Devices and Drugs Market Size by Country (2023-2035)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Medtronic
        11.1.1 Medtronic Company Details
        11.1.2 Medtronic Business Overview
        11.1.3 Medtronic Diabetes Devices and Drugs Introduction
        11.1.4 Medtronic Revenue in Diabetes Devices and Drugs Business (2017-2022)
        11.1.5 Medtronic Recent Developments
    11.2 BD
        11.2.1 BD Company Details
        11.2.2 BD Business Overview
        11.2.3 BD Diabetes Devices and Drugs Introduction
        11.2.4 BD Revenue in Diabetes Devices and Drugs Business (2017-2022)
        11.2.5 BD Recent Developments
    11.3 Johnson & Johnson
        11.3.1 Johnson & Johnson Company Details
        11.3.2 Johnson & Johnson Business Overview
        11.3.3 Johnson & Johnson Diabetes Devices and Drugs Introduction
        11.3.4 Johnson & Johnson Revenue in Diabetes Devices and Drugs Business (2017-2022)
        11.3.5 Johnson & Johnson Recent Developments
    11.4 Abbott Laboratories
        11.4.1 Abbott Laboratories Company Details
        11.4.2 Abbott Laboratories Business Overview
        11.4.3 Abbott Laboratories Diabetes Devices and Drugs Introduction
        11.4.4 Abbott Laboratories Revenue in Diabetes Devices and Drugs Business (2017-2022)
        11.4.5 Abbott Laboratories Recent Developments
    11.5 Novo Nordisk
        11.5.1 Novo Nordisk Company Details
        11.5.2 Novo Nordisk Business Overview
        11.5.3 Novo Nordisk Diabetes Devices and Drugs Introduction
        11.5.4 Novo Nordisk Revenue in Diabetes Devices and Drugs Business (2017-2022)
        11.5.5 Novo Nordisk Recent Developments
    11.6 Bristol-Myers Squibb
        11.6.1 Bristol-Myers Squibb Company Details
        11.6.2 Bristol-Myers Squibb Business Overview
        11.6.3 Bristol-Myers Squibb Diabetes Devices and Drugs Introduction
        11.6.4 Bristol-Myers Squibb Revenue in Diabetes Devices and Drugs Business (2017-2022)
        11.6.5 Bristol-Myers Squibb Recent Developments
    11.7 DexCom
        11.7.1 DexCom Company Details
        11.7.2 DexCom Business Overview
        11.7.3 DexCom Diabetes Devices and Drugs Introduction
        11.7.4 DexCom Revenue in Diabetes Devices and Drugs Business (2017-2022)
        11.7.5 DexCom Recent Developments
    11.8 Companion Medical
        11.8.1 Companion Medical Company Details
        11.8.2 Companion Medical Business Overview
        11.8.3 Companion Medical Diabetes Devices and Drugs Introduction
        11.8.4 Companion Medical Revenue in Diabetes Devices and Drugs Business (2017-2022)
        11.8.5 Companion Medical Recent Developments
    11.9 GlaxoSmithKline
        11.9.1 GlaxoSmithKline Company Details
        11.9.2 GlaxoSmithKline Business Overview
        11.9.3 GlaxoSmithKline Diabetes Devices and Drugs Introduction
        11.9.4 GlaxoSmithKline Revenue in Diabetes Devices and Drugs Business (2017-2022)
        11.9.5 GlaxoSmithKline Recent Developments
    11.10 Glenmark Pharmaceuticals
        11.10.1 Glenmark Pharmaceuticals Company Details
        11.10.2 Glenmark Pharmaceuticals Business Overview
        11.10.3 Glenmark Pharmaceuticals Diabetes Devices and Drugs Introduction
        11.10.4 Glenmark Pharmaceuticals Revenue in Diabetes Devices and Drugs Business (2017-2022)
        11.10.5 Glenmark Pharmaceuticals Recent Developments
    11.11 Novartis
        11.11.1 Novartis Company Details
        11.11.2 Novartis Business Overview
        11.11.3 Novartis Diabetes Devices and Drugs Introduction
        11.11.4 Novartis Revenue in Diabetes Devices and Drugs Business (2017-2022)
        11.11.5 Novartis Recent Developments
    11.12 Roche
        11.12.1 Roche Company Details
        11.12.2 Roche Business Overview
        11.12.3 Roche Diabetes Devices and Drugs Introduction
        11.12.4 Roche Revenue in Diabetes Devices and Drugs Business (2017-2022)
        11.12.5 Roche Recent Developments
    11.13 Sanofi
        11.13.1 Sanofi Company Details
        11.13.2 Sanofi Business Overview
        11.13.3 Sanofi Diabetes Devices and Drugs Introduction
        11.13.4 Sanofi Revenue in Diabetes Devices and Drugs Business (2017-2022)
        11.13.5 Sanofi Recent Developments
    11.14 MSD
        11.14.1 MSD Company Details
        11.14.2 MSD Business Overview
        11.14.3 MSD Diabetes Devices and Drugs Introduction
        11.14.4 MSD Revenue in Diabetes Devices and Drugs Business (2017-2022)
        11.14.5 MSD Recent Developments
    11.15 Astrazeneca
        11.15.1 Astrazeneca Company Details
        11.15.2 Astrazeneca Business Overview
        11.15.3 Astrazeneca Diabetes Devices and Drugs Introduction
        11.15.4 Astrazeneca Revenue in Diabetes Devices and Drugs Business (2017-2022)
        11.15.5 Astrazeneca Recent Developments
    11.16 Takeda
        11.16.1 Takeda Company Details
        11.16.2 Takeda Business Overview
        11.16.3 Takeda Diabetes Devices and Drugs Introduction
        11.16.4 Takeda Revenue in Diabetes Devices and Drugs Business (2017-2022)
        11.16.5 Takeda Recent Developments
    11.17 North China Pharmaceutical Group Corporation
        11.17.1 North China Pharmaceutical Group Corporation Company Details
        11.17.2 North China Pharmaceutical Group Corporation Business Overview
        11.17.3 North China Pharmaceutical Group Corporation Diabetes Devices and Drugs Introduction
        11.17.4 North China Pharmaceutical Group Corporation Revenue in Diabetes Devices and Drugs Business (2017-2022)
        11.17.5 North China Pharmaceutical Group Corporation Recent Developments
    11.18 Huadong Medicine
        11.18.1 Huadong Medicine Company Details
        11.18.2 Huadong Medicine Business Overview
        11.18.3 Huadong Medicine Diabetes Devices and Drugs Introduction
        11.18.4 Huadong Medicine Revenue in Diabetes Devices and Drugs Business (2017-2022)
        11.18.5 Huadong Medicine Recent Developments
    11.19 Dongbao Pharmaceutical
        11.19.1 Dongbao Pharmaceutical Company Details
        11.19.2 Dongbao Pharmaceutical Business Overview
        11.19.3 Dongbao Pharmaceutical Diabetes Devices and Drugs Introduction
        11.19.4 Dongbao Pharmaceutical Revenue in Diabetes Devices and Drugs Business (2017-2022)
        11.19.5 Dongbao Pharmaceutical Recent Developments
    11.20 Hisun Pharmacy
        11.20.1 Hisun Pharmacy Company Details
        11.20.2 Hisun Pharmacy Business Overview
        11.20.3 Hisun Pharmacy Diabetes Devices and Drugs Introduction
        11.20.4 Hisun Pharmacy Revenue in Diabetes Devices and Drugs Business (2017-2022)
        11.20.5 Hisun Pharmacy Recent Developments
    11.21 KELUN
        11.21.1 KELUN Company Details
        11.21.2 KELUN Business Overview
        11.21.3 KELUN Diabetes Devices and Drugs Introduction
        11.21.4 KELUN Revenue in Diabetes Devices and Drugs Business (2017-2022)
        11.21.5 KELUN Recent Developments
    11.22 Ginwa
        11.22.1 Ginwa Company Details
        11.22.2 Ginwa Business Overview
        11.22.3 Ginwa Diabetes Devices and Drugs Introduction
        11.22.4 Ginwa Revenue in Diabetes Devices and Drugs Business (2017-2022)
        11.22.5 Ginwa Recent Developments
    11.23 Tianan Pharmaceutical
        11.23.1 Tianan Pharmaceutical Company Details
        11.23.2 Tianan Pharmaceutical Business Overview
        11.23.3 Tianan Pharmaceutical Diabetes Devices and Drugs Introduction
        11.23.4 Tianan Pharmaceutical Revenue in Diabetes Devices and Drugs Business (2017-2022)
        11.23.5 Tianan Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global Diabetes Devices and Drugs Market